Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Soni

Showing results (221-230 of 232) with videos related to

Pageof 24
Sort By:
Spinal Cord|January 19, 2005
Recurrent vesical calculi, hypercalciuria, and biochemical evidence of increased bone resorption in an adult male with paraplegia due to spinal cord injury: is there a role for intermittent oral disodium etidronate therapy for prevention of calcium phosphate bladder stones?S Vaidyanathan, I D Watson, O Jonsson, et al.
Spinal Cord|April 13, 2011
Expected spinal cord independence measure, third version, scores for various neurological levels after complete spinal cord lesionsE Aidinoff, L Front, M Itzkovich, et al.
Spinal Cord|September 8, 2010
SCIM III is reliable and valid in a separate analysis for traumatic spinal cord lesionsV Bluvshtein, L Front, M Itzkovich, et al.
Disability and Rehabilitation|September 14, 2007
The Spinal Cord Independence Measure (SCIM) version III: reliability and validity in a multi-center international studyM Itzkovich, I Gelernter, F Biering-Sorensen, et al.
Spinal Cord|August 16, 2006
A multicenter international study on the Spinal Cord Independence Measure, version III: Rasch psychometric validationA Catz, M Itzkovich, L Tesio, et al.
Frontiers in Aging Neuroscience|July 11, 2022
<i>Plcg2</i> Interacts With High Fat/High Sugar Diet to Accelerate Alzheimer's Disease-Relevant Phenotypes in MiceAdrian L Oblak, Kevin P Kotredes, Ravi S Pandey, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 27, 2022
AD Informer Set: Chemical tools to facilitate Alzheimer's disease drug discoveryFrances M Potjewyd, Joel K Annor-Gyamfi, Jeffrey Aubé, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 18, 2022
Use of AD Informer Set compounds to explore validity of novel targets in Alzheimer's disease pathologyFrances M Potjewyd, Joel K Annor-Gyamfi, Jeffrey Aubé, et al.
Spinal Cord|August 3, 2011
A new grading for easy and concise description of functional status after spinal cord lesionsV Bluvshtein, L Front, M Itzkovich, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 29, 2023
SHIP1 therapeutic target enablement: Identification and evaluation of inhibitors for the treatment of late-onset Alzheimer's diseaseCynthia D Jesudason, Emily R Mason, Shaoyou Chu, et al.
Pageof 24

Showing results (221-230 of 232) with videos related to

Sort By:
Pageof 24
Spinal Cord|January 19, 2005
Recurrent vesical calculi, hypercalciuria, and biochemical evidence of increased bone resorption in an adult male with paraplegia due to spinal cord injury: is there a role for intermittent oral disodium etidronate therapy for prevention of calcium phosphate bladder stones?S Vaidyanathan, I D Watson, O Jonsson, et al.
Spinal Cord|April 13, 2011
Expected spinal cord independence measure, third version, scores for various neurological levels after complete spinal cord lesionsE Aidinoff, L Front, M Itzkovich, et al.
Spinal Cord|September 8, 2010
SCIM III is reliable and valid in a separate analysis for traumatic spinal cord lesionsV Bluvshtein, L Front, M Itzkovich, et al.
Disability and Rehabilitation|September 14, 2007
The Spinal Cord Independence Measure (SCIM) version III: reliability and validity in a multi-center international studyM Itzkovich, I Gelernter, F Biering-Sorensen, et al.
Spinal Cord|August 16, 2006
A multicenter international study on the Spinal Cord Independence Measure, version III: Rasch psychometric validationA Catz, M Itzkovich, L Tesio, et al.
Frontiers in Aging Neuroscience|July 11, 2022
<i>Plcg2</i> Interacts With High Fat/High Sugar Diet to Accelerate Alzheimer's Disease-Relevant Phenotypes in MiceAdrian L Oblak, Kevin P Kotredes, Ravi S Pandey, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 27, 2022
AD Informer Set: Chemical tools to facilitate Alzheimer's disease drug discoveryFrances M Potjewyd, Joel K Annor-Gyamfi, Jeffrey Aubé, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 18, 2022
Use of AD Informer Set compounds to explore validity of novel targets in Alzheimer's disease pathologyFrances M Potjewyd, Joel K Annor-Gyamfi, Jeffrey Aubé, et al.
Spinal Cord|August 3, 2011
A new grading for easy and concise description of functional status after spinal cord lesionsV Bluvshtein, L Front, M Itzkovich, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 29, 2023
SHIP1 therapeutic target enablement: Identification and evaluation of inhibitors for the treatment of late-onset Alzheimer's diseaseCynthia D Jesudason, Emily R Mason, Shaoyou Chu, et al.
Pageof 24